ImaginAb’s Post

Check our latest Perspective’s blog by Matthew Hoover. Explore the transformative power of immuno-oncology therapies targeting CTLA-4, PD-1, and PD-L1, enhancing the immune system’s ability to fight tumors. While offering new hope, these treatments also present unique challenges, including immune-related adverse events (irAEs) that mirror autoimmune disorders and can impact any organ system. Early detection and management of irAEs are vital for patient outcomes. This blog delves into traditional and innovative methods for identifying irAEs, from clinical observation to advanced molecular imaging, ensuring optimized treatment and patient care. Read here: https://lnkd.in/gQgP4X99 #ImmunoOncology #CancerTreatment #irAEs #InnovationInHealthcare #CD8ImmunoPET #immunooncology #immunotherapy

  • graphical user interface, text, application, chat or text message
Judy Currier

Chief Commercial Officer at RadMD, a Medica Company

3mo

Congrats Matthew Hoover on this article!

To view or add a comment, sign in

Explore topics